![]() Washington Post | Health Highlights: Dec. 3 2006 Washington Post - The world's largest drugmaker has shut down development of its star cholesterol drug because of an unexpected number of deaths and cardiovascular problems in patients who used it. Pfizer under pressure to cut costs Pfizer Ends Cholesterol Drug Development |